p53 activating benzoyl urea and benzoyl thiourea compounds

Sonia Lain; David Lane; Michael John Raymond Stark; Anna Rose McCarthy; Jonathan James Hollick; Nicholas James Westwood

p53 activating benzoyl urea and benzoyl thiourea compounds

Sonia Lain (Inventor), David Lane (Inventor), Michael John Raymond Stark (Inventor), Anna Rose McCarthy (Inventor), Jonathan James Hollick (Inventor), Nicholas James Westwood (Inventor)

Research output: Patent

Abstract

The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).

Original language	English
Patent number	WO2008029096
IPC	A61K31/17
Publication status	Published - 13 Mar 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

http://patentscope.wipo.int/search/en/WO2008029096

Cite this

@misc{bfabb8e23123488587ffd5cff8b88669,

title = "p53 activating benzoyl urea and benzoyl thiourea compounds",

abstract = "The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).",

author = "Sonia Lain and David Lane and Stark, {Michael John Raymond} and McCarthy, {Anna Rose} and Hollick, {Jonathan James} and Westwood, {Nicholas James}",

year = "2008",

month = mar,

day = "13",

language = "English",

type = "Patent",

note = "WO2008029096; A61K31/17",

}

TY - PAT

T1 - p53 activating benzoyl urea and benzoyl thiourea compounds

AU - Lain, Sonia

AU - Lane, David

AU - Stark, Michael John Raymond

AU - McCarthy, Anna Rose

AU - Hollick, Jonathan James

AU - Westwood, Nicholas James

PY - 2008/3/13

Y1 - 2008/3/13

N2 - The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).

AB - The present invention relates to compounds which acivate the p53 response, and find use in, for example, hyperproliferative diseases such as cancer treatment and potentially other diseases/conditions (involving sirtuin function).

M3 - Patent

M1 - WO2008029096

ER -

p53 activating benzoyl urea and benzoyl thiourea compounds

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this